Table III.
Parameter | Hazard ratio (95% confidence interval) |
P value |
---|---|---|
At Complete Remission (N=260) | ||
| ||
Age | 1.017 (1.005, 1.029) | 0.006 |
WBC | 1.003 (1.002, 1.005) | <0.0001 |
Cytogenetics | 0.89 (0.61, 1.30) | 0.54 |
MRD at CR | 1.47 (1.003, 2.153) | 0.048 |
| ||
At 3 Months from Therapy Initiation (N=215) | ||
| ||
Age | 1.016 (1.004, 1.028) | 0.01 |
WBC | 1.003 (1.002, 1.005) | <0.0001 |
Cytogenetics | 0.92 (0.64, 1.34) | 0.68 |
MRD at 3 Months | 1.72 (0.79, 3.73) | 0.17 |
| ||
At 6 Months from Therapy Initiation (N=166) | ||
| ||
Age | 1.015 (1.003, 1.027) | 0.014 |
WBC | 1.003 (1.001, 1.005) | 0.0003 |
Cytogenetics | 0.98 (0.67, 1.42) | 0.90 |
MRD at 6 Months | 2.12 (0.70, 6.44) | 0.18 |
WBC, white blood cell count; MRD, minimal residual disease; CR, complete remission